Novel, specific inhibitors of 11β-hydroxysteroid dehydrogenase type I with potent in-vitro and in-vivo activity

被引：0
|
作者：
Suri, Vipin
Xiang, Jason
Li, Xiangping
Panza, Darell
Xing, Yuzhe
Zrang, Yan-Ling
Rajan, Sonsy
Jin, Guixan
Aulabaugh, Ann
Hahm, Seung
Qadri, Ariful
Perreault, Mylene
Klaman, Lori
McKew, John
Saiah, Eddine
Tam, Steve
Celeste, Anthony J.
Tobin, James F.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A479 / A479
页数：1
相关论文
共 50 条
  • [1] FUROSEMIDE INHIBITS 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN-VITRO AND IN-VIVO
    ESCHER, G
    MEYER, KV
    VISHWANATH, BS
    FREY, BM
    FREY, FJ
    ENDOCRINOLOGY, 1995, 136 (04) : 1759 - 1765
  • [2] FUROSEMIDE INHIBITS 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN-VITRO AND IN-VIVO
    MEYER, KV
    ESCHER, G
    VISHWANATH, BS
    FREY, BM
    FREY, FJ
    KIDNEY INTERNATIONAL, 1995, 48 (01) : 298 - 299
  • [3] In-vivo quantification of hepatic 11β-hydroxysteroid dehydrogenase type I activity -: a preliminary study
    Vogeser, M
    Gülberg, V
    Waggershauser, T
    Gerbes, AL
    CLINICAL BIOCHEMISTRY, 2002, 35 (08) : 655 - 657
  • [4] Oxazolones as potent inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Sutin, Lori
    Andersson, Soeren
    Bergquist, Lars
    Castro, Victor M.
    Danielsson, Eva
    James, Stephen
    Henriksson, Martin
    Johansson, Lars
    Kaiser, Christina
    Flyren, Katarina
    Williams, Meredith
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) : 4837 - 4840
  • [5] Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies
    Ali, Anser
    Ashraf, Zaman
    Rafiq, Muhammad
    Kumar, Ajeet
    Jabeen, Farukh
    Lee, Goon Joon
    Nazir, Fahad
    Ahmed, Mushtaq
    Rhee, Myungchull
    Choi, Eun Ha
    MEDICINAL CHEMISTRY, 2019, 15 (07) : 715 - 728
  • [6] Novel and potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors
    Lawrence, HR
    Vicker, N
    Allan, GM
    Smith, A
    Mahon, MF
    Tutill, HJ
    Purohit, A
    Reed, MJ
    Potter, BVL
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) : 2759 - 2762
  • [7] Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type I
    Roche, Didier
    Carniato, Denis
    Leriche, Caroline
    Lepifre, Franck
    Christmann-Franck, Serge
    Graedler, Ulrich
    Charon, Christine
    Bozec, Sophie
    Doare, Liliane
    Schmidlin, Fabien
    Lecomte, Marc
    Valeur, Eric
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2674 - 2678
  • [8] Discovery of amidines as a novel class of potent and selective 11β- hydroxysteroid dehydrogenase Type 1 inhibitors
    Patel, Meena V.
    Peddi, Sridhar
    Rohde, Jeffrey J.
    Lange, Udo E. W.
    Hornberger, Wilfried
    Backfisch, Gisela
    Shebly, Mohamad
    Jacobson, Peer
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [9] Perhydroquinolylbenzamides as novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Coppola, GM
    Kukkola, PJ
    Stanton, JL
    Neubert, AD
    Marcopulos, N
    Bilci, NA
    Wang, H
    Tomaselli, HC
    Tan, J
    Aicher, TD
    Knorr, DC
    Jeng, AY
    Dardik, B
    Chatelain, RE
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) : 6696 - 6712
  • [10] Pyridine amides as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Wang, Haixia
    Ruan, Zheming
    Li, James J.
    Simpkins, Ligaya M.
    Smirk, Rebecca A.
    Wu, Shung C.
    Hutchins, Robert D.
    Nirschl, David S.
    Van Kirk, Katy
    Cooper, Christopher B.
    Sutton, James C.
    Ma, Zhengping
    Golla, Rajasree
    Seethala, Ramakrishna
    Salyan, Mary Ellen K.
    Nayeem, Akbar
    Krystek, Stanley R., Jr.
    Sheriff, Steven
    Camac, Daniel M.
    Morin, Paul E.
    Carpenter, Brian
    Robl, Jeffrey A.
    Zahler, Robert
    Gordon, David A.
    Hamann, Lawrence G.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (11) : 3168 - 3172
12345